Breast Cancer

  • Abraxane 2018 report

    Abraxane 2018 U.S. PROMOTIONAL AUDIT REPORT Published July 2019 • 29 Pages The 5 Key Questions Addressed by this Report:...

  • Afinitor 2018 report

    Afinitor 2018 U.S. PROMOTIONAL AUDIT REPORT Published July 2019 • 31 Pages The 5 Key Questions Addressed by this Report:...

  • Avastin 2018 report

    Avastin 2018 U.S. PROMOTIONAL AUDIT REPORT Published July 2019 • 25 Pages The 5 Key Questions Addressed by this Report:...

  • Fareston 2018 report

    Fareston 2018 U.S. PROMOTIONAL AUDIT REPORT Published July 2019 • 24 Pages The 5 Key Questions Addressed by this Report:...

  • Faslodex 2018 report

    Faslodex 2018 U.S. PROMOTIONAL AUDIT REPORT Published July 2019 • 29 Pages The 5 Key Questions Addressed by this Report:...

  • Halaven 2018 report

    Halaven 2018 U.S. PROMOTIONAL AUDIT REPORT Published July 2019 • 26 Pages The 5 Key Questions Addressed by this Report:...

  • Herceptin 2018 report

    Herceptin 2018 U.S. PROMOTIONAL AUDIT REPORT Published July 2019 • 24 Pages The 5 Key Questions Addressed by this Report:...

  • Ibrance 2018 report

    Ibrance 2018 U.S. PROMOTIONAL AUDIT REPORT Published July 2019 • 21 Pages The 5 Key Questions Addressed by this Report:...

  • Ixempra 2018 report

    Ixempra 2018 U.S. PROMOTIONAL AUDIT REPORT Published July 2019 • 24 Pages The 5 Key Questions Addressed by this Report:...

  • Kadcyla 2018 report

    Kadcyla 2018 U.S. PROMOTIONAL AUDIT REPORT Published July 2019 • 19 Pages The 5 Key Questions Addressed by this Report:...

  • Kisqali 2018 report

    Kisqali 2018 U.S. PROMOTIONAL AUDIT REPORT Published July 2019 • 24 Pages The 5 Key Questions Addressed by this Report:...

  • Lynparza 2018 report

    Lynparza 2018 U.S. PROMOTIONAL AUDIT REPORT Published July 2019 • 26 Pages The 5 Key Questions Addressed by this Report:...